In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
June 20th, 2008 | 28 | Yes |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.29 | 4.36 | -54.67 | 3 | 6 | -1 | 110 | 389.468 | 11 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
PUBCHEM_PATENT_ID | US4105792; US4159343; US4256745 | IBM Patent Data |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
PF2R-1-E | Prostaglandin F2-alpha Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2 | 0.43 | Binding ≤ 10μM |
PE2R1-2-E | Prostanoid EP1 Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 38 | 0.37 | Functional ≤ 10μM |
PE2R3-2-E | Prostanoid EP3 Receptor (cluster #2 Of 2), Eukaryotic | Eukaryotes | 186 | 0.34 | Functional ≤ 10μM |
TA2R-1-E | Thromboxane A2 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 510 | 0.31 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
PF2R_HUMAN | P43088 | Prostanoid FP Receptor, Human | 2 | 0.43 | Binding ≤ 1μM |
PF2R_HUMAN | P43088 | Prostanoid FP Receptor, Human | 2 | 0.43 | Binding ≤ 10μM |
PE2R1_HUMAN | P34995 | Prostanoid EP1 Receptor, Human | 38 | 0.37 | Functional ≤ 10μM |
PE2R3_HUMAN | P43115 | Prostanoid EP3 Receptor, Human | 186 | 0.34 | Functional ≤ 10μM |
TA2R_HUMAN | P21731 | Thromboxane A2 Receptor, Human | 510 | 0.31 | Functional ≤ 10μM |
Description | Species |
---|---|
G alpha (12/13) signalling events | |
G alpha (i) signalling events | |
G alpha (q) signalling events | |
Prostanoid ligand receptors | |
Thromboxane signalling through TP receptor |